ArticleMaterials today. Bio2025

Harnessing engineered exosomes as METTL3 carriers: Enhancing osteogenesis and suppressing lipogenesis in bone marrow mesenchymal stem cells for postmenopausal osteoporosis treatment.

Tao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.